Immunosuppressants Flashcards
What are the major clinical conditions for which immunosuppressants are most commonly used?
Transplantation
Autoimmune disease
Inflammatory disease
Glucocorticoids Characteristics: MOA: USes: AE
Characteristics: decrease blood lymphocytes, downreg key cytokines, inhibit IL-2 prod by T cells, Reduce neutrophil chemotaxis. little effect on humoral immunity
MOA: binds to receptor in cytosol, or intercalates into the membrane and messes up cell signaling
USes: transplant, AI dz, Inflamm
AE: Growth retard, infection, wound heal, HTN, avascular necrosis of bone, cataracts, hyperglycemia, adrenal crisis
Define the nomenclature used to describe Prednisone equivalent dosages
*****
Low dose: equiv of less than 7.5 mg prednisone
Med Dose: Between 7.5 and 30 mg prednisone
High dose: greater than 30 mg per day
Very high dose: greater than 100 mg/day
Pulse therapy: greater than 250 mg/day
Cyclosporins Characteristics: MOA: USes: AE *****
Characteristics: from fungus, iv and oral
MOA: suppresses T cell mediated immunity. Binds to cyclophilin then activates calcineurin, which prevents the dephosphorylation of NFAT - no translocation to nucleus and no cytokines from T cells.
USes: RA, Transplant, Psoriasis, usually combined
AE: Nephrotoxicity, HTN, Hyperlipidemia, Tremors, swollen gums, Hirsutism, skin ca,
Tacrolimus Characteristics: MOA: USes: AE
Characteristics: from fungus strep tsukubaensis
MOA: Calcineurin inhibitor, no dephosphorylation of NFAT - no translocation to nucleus, no cytokines from T cells
USes: prophylaxis for allograft rejection
AE: Nephrotoxicity, HTN, DM, Neurotoxicity, Concen can be inc by grapefruit juice
Azathioprine Characteristics: MOA: USes: AE
Characteristics: oral or iv, purine antimetabolite
MOA: conv to 6 MP decreases purines, lymphocytes dont have a good purine salvage pathway and die
USes: Prevent rejection, RA, Crohn’s, MS, etc
AE: Hepatotoxicity, Bone marrow suppress, Chicken pox, Ca risk elev
Mycophenolate Mofetil Characteristics: MOA: USes: AE
Characteristics: oral iv
MOA: inhibitor of Inosiune monophosphate dehydrogenase - no guanine nt. B and T cells need this.
USes: prevent transplant rejection. combo w/glucocorticoids/calcineurin inhib
AE: Hematologic, GI, CMV, Preg congenital
Sirolimus Characteristics: MOA: USes: AE
Characteristics: from fungus strep hygroscopius Oral only
MOA: inhib T cell prolif by binding to FKBP, similar to tacrolimus, but instead of inhibiting calcineurin, this inhibits MTOR
USes: transplant rejection, alternative to calcineurin inhibitors
AE: infections, neoplasms risk
Antithymocyte Globulin Characteristics: MOA: USes: AE
Characteristics: Rabbit, resuspend in water
MOA: Contains AB that bind to CDlots of #s, on surface of T cells. antibodies deplete them by both Complement mediated cytotoxicity and Inhibition of lymphocyte functions - both kill it and inhibit the rest
USes: Intense immunosuppression in time right after transplant, tx of acute rejection
AE: serum sickness, cytokine storm
Muromonab-CD3 Characteristics: MOA: USes: AE
Characteristics: Mouse ab directed against CD 3
MOA: ab directed here kill t cell. also kills and inactivates
USes: Glucocorticoid resistant rejection episodes. T cells are gone withing a few minutes of administering. Can only use 1x bc body makes ab against it
AE: Cytokine storm! Prior glucocorticoid administration redues this rxn
Anti-TNF alpha reagents Characteristics: MOA: USes: AE ******
Characteristics:
Infliximab - mouse human
Adalimumab - Human igG
Etanercept - Human TNF alpha/IgG mix
MOA: bind directly to TNF alpha to keep frmo binding to its receptor
USes: RA if MTX has failed, Crohn’s who failed, B27 diseases
AE: Serious infections, lymphomas/malignancies